Results 101 to 110 of about 59,458 (179)

New Drugs: Naltrexone hydrochloride

Australian Prescriber, 1999
openaire   +1 more source

Nalmefene and naltrexone reduce alcohol intake via selective efficacy in subpopulations distinguished by behavioral and blood-based biomarkers. [PDF]

Commun Med (Lond)
Farahbakhsh ZZ, Brown AR, Nolan SO, Mukerjee S, Siciliano CA.   +4 more
europepmc   +1 more source

Exploring the association between sweet liking and treatment response to naltrexone in patients with alcohol use disorder. [PDF]

Int J Neuropsychopharmacol
Chang MC, Chen CH, Meng SC, Shu SH, Chang HM, Huang MC.   +5 more
europepmc   +1 more source

Quantitative assessment of light discomfort thresholds in a patient with photoallodynia treated with topical naltrexone 0.01. [PDF]

Am J Ophthalmol Case Rep
Lixi F, Coco G, Calabresi V, Vitiello L, Corda C, Verdiglione M, Costa S, Giannaccare G.   +7 more
europepmc   +1 more source

Cardiovascular effects of a selective 5-HT4 agonist and an alpha-2 adrenoceptor antagonist in etorphine immobilised sheep (Ovis aries) - a randomised, prospective, and controlled trial. [PDF]

BMC Vet Res
Rattanathanya H, Binetti A, Pohlin F, Ferreira SCM, Braun C, Schramel J, Meyer LCR, Haw A, Raekallio M, Böhmdorfer S, Kalogeropoulu S, Mosing M, Stalder G.   +12 more
europepmc   +1 more source

Extemporaneous Preparation and Effectiveness of Low-Dose Naltrexone for the Treatment of Uremic Pruritus: A Literature Review and Case Report. [PDF]

Pharmacy (Basel)
Rungkitwattanakul D, Brooks M, Adesina S, Belrhiti S, Chaijamorn W, Charoensareerat T, Nwaogwugwu U, Mere C.   +7 more
europepmc   +1 more source

Investigating the Landscape of C6-Azaindole Side Chain on the Epoxymorphinan Skeleton via the Nitrogen Walk Concept: A Strategy to Enhance Drug-Like Properties. [PDF]

J Med Chem
Neel L, Ma H, Reda A, Li M, Flammia R, Woodard S, Gillespie JC, Selley DE, Dewey WL, Pagare PP, Zhang Y.   +10 more
europepmc   +1 more source

Structural Determinants of μ-Opioid Receptor Antagonism and Respiratory Liability in Phenylfentanyl Analogues. [PDF]

ACS Chem Neurosci
Li E, Kale BS, Silte AA, Lyu R, Upadhyay N, Neel LT, Reda A, Wang H, Dewey WL, Pagare PP, Zhang Y.   +10 more
europepmc   +1 more source

Development of Delta Opioid Receptor Antagonists Which Prevent Alzheimer's Disease-Like Pathology in the 5X-Familial Alzheimer's Disease [5XFAD] Mouse Model. [PDF]

ACS Pharmacol Transl Sci
Tanguturi P, Mitchell S, Moukha-Chafiq O, Zhang S, Tillotson J, Ananthan S, Augelli-Szafran CE, Streicher JM.   +7 more
europepmc   +1 more source

Candidate treatments for long COVID: a narrative review of expert and patient-driven priorities. [PDF]

Front Med (Lausanne)
Baptista SN, Atkins T, Chakraborty S, Bakhit M, Glasziou P, Byambasuren O.   +5 more
europepmc   +1 more source